CBY1 and cancer: CBY1, also known as β-cyclin antagonist, is a protein-coding gene that competes with transcription factors for binding to β-cyclin, a transcriptional activator and oncoprotein involved in the development of several cancers, to inhibit its mediated transcriptional activation.